Evidence map›Paper›PMID 40883995›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Peptidic Tryptophan Halogenation by a Promiscuous Flavin-Dependent Enzyme.

Andrew J Rice, Mayuresh G Gadgil, Paola Bisignano, Richard A Stein, Hassane S Mchaourab, Douglas A Mitchell

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Tangled Tail of Mechanically Interlocked Peptides.Journal of the American Chemical Society · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Peptidic Tryptophan Halogenation by a Promiscuous Flavin-Dependent Enzyme.Angewandte Chemie (International ed. in English) · 2025
    Article
  7. Article
  8. Peptide halogenation biochemistry: interfacing pharmaceutical deliverables with chemical innovation.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrew J Rice *Department of Biochemistry, Vanderbilt University School of Medicine-Basic Science, Department of Chemistry, Vanderbilt University, Nashville, TN, 37232, USA.
Mayuresh G Gadgil *Department of Chemistry, University of Illinois Urbana-Champaign, Urbana, IL, 61801, USA.
Paola BisignanoDepartment of Molecular Physiology and Biophysics, Center for AI in Protein Dynamics, Vanderbilt University, Nashville, TN, 37232, USA.
Richard A SteinDepartment of Molecular Physiology and Biophysics, Center for AI in Protein Dynamics, Vanderbilt University, Nashville, TN, 37232, USA.
Hassane S MchaourabDepartment of Molecular Physiology and Biophysics, Center for AI in Protein Dynamics, Vanderbilt University, Nashville, TN, 37232, USA.
Douglas A MitchellDepartment of Biochemistry, Vanderbilt University School of Medicine-Basic Science, Department of Chemistry, Vanderbilt University, Nashville, TN, 37232, USA.ORCID 0000-0002-9564-0953

Funding

Structural Dynamics of Active TransportersR35GM152382 · NIGMS · VANDERBILT UNIVERSITY · PI Hassane S Mchaourab · 2024 to 2026
$1.7M
Discovery and Engineering of RiPP Natural ProductsR35GM158411 · NIGMS · VANDERBILT UNIVERSITY · PI Douglas Alan Mitchell · 2025 to 2026
$1.2M
NIGMS NIH HHS R35 GM152382NIGMS NIH HHS R35 GM158411
6 · The paper itself

Abstract

Amino acids undergo numerous enzymatic modifications. However, the broad applicability of amino acid-modifying enzymes for synthetic purposes is limited by narrow substrate scope and often unknown regulatory or accessory factor requirements. Here, we characterize ChlH, a flavin-dependent halogenase (FDH) from the chlorolassin biosynthetic gene cluster. Unlike characterized peptide-modifying FDHs, which are limited to either specifically modified peptides or the termini of linear peptides, ChlH halogenates internal Trp residues of linear peptides, as well as N- and C-terminal Trp. Scanning mutagenesis of the substrate peptide ChlA revealed Trp was tolerated by ChlH at nearly every position. Molecular dynamics simulations corroborated the importance of a C-terminal motif in ChlA and provided insight into the lack of Trp14 chlorination in native chlorolassin. Furthermore, halogenation of disparate ribosomally synthesized and post-translationally modified peptide (RiPP) precursor peptides, pharmacologically relevant peptides, and special examples of internal Trp within proteins was achieved using wild-type ChlH. A rapid cell-free biosynthetic assay provided insight into ChlH's preferences. In contrast to characterized FDHs, ChlH halogenates diverse peptide sequences, and we predict this promiscuity may find utility in the modification of additional peptide and protein substrates of biotechnological value.

Indexed as

FlavinsOxidoreductasesPeptidesTryptophanHalogenationMolecular Dynamics SimulationFlavinsOxidoreductasesPeptidesTryptophantryptophan halogenaseBiocatalysisChlorineHalogenationPeptideProteins

Identifiers

PMID40883995
PMCPMC12518702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.